CASI Pharma (CASI) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03).
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- AbbVie updates 2026 EPS guidance after $291M IPR&D charge
- Barclays Starts Sabra Healthcare REIT Inc. (SBRA) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
